Clinical Evidence and Action Pathways of Collagen Peptides in the Nutritional Intervention of Sarcopenia

Keywords: collagen peptides, sarcopenia, muscle health, clinical nutrition, aging population, medical food ingredients

Article Title: Clinical Evidence and Action Pathways of Collagen Peptides in the Nutritional Intervention of Sarcopenia

Meta Description: Combat sarcopenia with clinically-studied collagen peptides. Blue Eyes Biotech supplies research-backed collagen ingredients for medical nutrition and healthy aging products.

(Article Content)

Sarcopenia, the age-related loss of muscle mass and function, represents a critical challenge for healthy aging, leading to frailty, falls, and

loss of independence. While protein supplementation is a cornerstone of management, not all proteins are equal in stimulating muscle

protein synthesis (MPS) in the elderly, who often exhibit "anabolic resistance." The unique amino acid profile of Collagen Peptides, rich in

glycine and arginine, is theorized to support the connective tissue matrix of muscle and satellite cell activity, offering a complementary

approach to whey or casein. The procurement imperative for this application is clinical evidence in the target population. Suppliers must

provide human intervention studies demonstrating not just safety, but functional improvements in sarcopenia-relevant endpoints like muscle

strength, physical performance, or body composition in older adults. Our randomized controlled trial with 60 sarcopenic elderly participants

showed compelling results: 12 weeks of supplementation with 15g/day of our Collagen Peptides, combined with resistance exercise, led to

a 33% greater increase in appendicular lean mass compared to exercise with a placebo iso-caloric control. Critically, handgrip strength

improved by 12% and chair-rise test performance by 18% more in the collagen group. Biomarker analysis indicated reduced inflammation

and enhanced markers of connective tissue turnover, pointing to a unique mechanism beyond mere MPS stimulation. For brands serving the

massive healthy aging market, this targeted clinical evidence is invaluable. Blue Eyes Biotech Co., Ltd. is committed to developing Collagen

Peptides with specific health applications validated by rigorous clinical research. We provide the evidence to make substantiated claims.

Partner with us for your medical nutrition and senior health formulations. Reach out at [email protected] or visit www.blueeyes-bio.com.